A novel 18F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography another way to avoid the need of an on-site cyclotron

Circulation: Cardiovascular Imaging

Volumn 2, Issue 2, 2009, Pages 75-76

  Camici, Paolo G ^a,b,d   Rimoldi, Ornella E ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Editorials; Imaging

Indexed keywords

BMS 74715802; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; RUBIDIUM 82; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ANGIOCARDIOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CYCLOTRON; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EDITORIAL; ESSENTIAL HYPERTENSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; MICROCIRCULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY CHAIN; RISK FACTOR; SMOKING; STANDARDIZATION; CORONARY ARTERY BLOOD FLOW; NOTE; SCINTISCANNING;

CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FLUORINE RADIOISOTOPES; HUMANS; MICROCIRCULATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 70350074244     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.855791     Document Type: Editorial

References (16)

1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318-1333.
2. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
3. Sambuceti G, Parodi O, Marzullo P, Giorgetti A, Fusani L, Puccini G, Salvadori P, L'Abbate A. Regional myocardial blood flow in stable angina pectoris associated with isolated significant narrowing of either the left anterior descending or left circumflex coronary artery. Am J Cardiol. 1993;72:990-994.
4. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-1951.
5. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronaryartery stenosis. N Engl J Med. 1994;330:1782-1788.
6. Uren NG, Marraccini P, Gistri R, De Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol. 1993;22:650-658.
7. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75-88.
8. Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, Dorbala S, Popma JJ, Di Carli MF. Quantitative relationship between coronary vasodilator reserve assessed by (82)Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008;35:1593-1601.
9. Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-1774. (Pubitemid 47599057)
10. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004;44:1533-1542.
11. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30-36.
12. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103-114.
13. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733-2743.
14. Chareonthaitawee P, Schaefers K, Baker CS, Turkheimer F, Stegger L, Banner NR, Yacoub M, Bonser RS, Iozzo P, Camici PG, Rimoldi O. Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D- glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging. 2002;29:203-215.
15. 18F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats. Circ Cardiovasc Imaging. 2009;2:77-84.
16. Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, Ziegler SI, Casebier DS, Robinson SP, Schwaiger M. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med. 2008;49:630-636.